Kailera Therapeutics Quarterly Balance Sheet
NASDAQ: KLRAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Kailera Therapeutics financial position
As of Jun 30, 2026, Kailera Therapeutics reported total assets of $1.21 billion against total liabilities of $93.0 million. Shareholders' equity stood at $1.12 billion, or 92.3% of assets. The company held $130.3 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 11.11, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Kailera Therapeutics balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q? 20252025-06-30 | Q? 20252025-03-31 |
|---|---|---|---|---|
| Cash & Equivalents | 130.30M | 111.83M | 101.37M | 101.78M |
| Short-Term Investments | 786.44M | 407.35M | — | — |
| Total Current Assets | 929.17M | 530.32M | — | — |
| Property, Plant & Equipment | 1.75M | 1.85M | — | — |
| Long-Term Investments | 255.08M | 62.75M | — | — |
| Total Assets | 1.21B | 624.76M | — | — |
| Accounts Payable | 19.20M | 7.09M | — | — |
| Total Current Liabilities | 83.65M | 54.84M | — | — |
| Total Liabilities | 92.95M | 64.48M | — | — |
| Shareholders' Equity | 1.12B | -432.09M | -262.58M | -235.24M |
| Retained Earnings | -558.84M | -447.53M | — | — |
| Net Cash (Debt) | 916.74M | 519.17M | 101.37M | 101.78M |
| Shares Outstanding | 129.62M | 29.95K | — | — |
This table shows 4 quarterly periods of Kailera Therapeutics's balance sheet, from Q2 2026 back to Q? 2025, across 13 line items including cash & equivalents, short-term investments, total current assets. Values in USD; B = billions, M = millions. Fiscal periods follow KLRA's reporting calendar. What is a balance sheet?